A fundamental obstacle in autism drug development has been the inadequacy of traditional animal models to replicate the intricate social behaviors disrupted in ASD. Rodents, primarily mice, have long been the mainstay for genetic and pharmacological investigations due to their genetic tractability and cost-effectiveness in laboratory environments. However, mice, by nature, lack the sophisticated social cognition that characterizes human interaction—they neither read subtle facial expressions nor engage in nuanced interpersonal communication mediated by eye contact and gaze. Non-human primates, while behaviorally closer to humans, present their own set of challenges; their slow reproductive cycles, high maintenance costs, and fundamentally different social signaling—where steady human gaze can be perceived as threatening—limit their utility for autism-related sociability studies. Consequently, drugs demonstrating efficacy in such models frequently fail to translate clinically, underscoring a crucial disconnect.

This Perspective article, led by Dr. Siqi Yuan and colleagues at Hubei University, brings into focus the canine species, particularly laboratory Beagles, as a previously underappreciated model that naturally exhibits a high degree of social attunement to humans. Unlike other laboratory animals, dogs have undergone approximately 30,000 years of co-evolution with humans, resulting in a neural architecture finely tuned to interpret human social cues, including eye gaze, facial expressions, and vocal intonations. This shared social circuitry implies that dogs can manifest behavioral phenotypes that align more closely with the social impairments characteristic of ASD in humans. The authors argue that this evolutionary legacy equips dogs to serve as an optimal translational bridge for autism research, capable of revealing both biological mechanisms and therapeutic targets that remain elusive in other species.

Central to the synthesis is a discussion of genetically engineered dogs bearing mutations in the Shank3 gene, a genetic locus robustly implicated in the etiology of autism in humans. Shank3 encodes a synaptic scaffolding protein critical for proper neural communication, and its disruption is associated with social withdrawal, sensory processing abnormalities, and altered pain perception—hallmarks of ASD. These gene-edited dogs display strikingly human-like behavioral and neurological traits: they avoid sustained eye contact, exhibit heightened sensitivity or diminished responses to sensory stimuli, and demonstrate social withdrawal patterns mirroring clinical observations in autistic individuals. The authors meticulously summarize emerging data into an integrative framework that traces shared phenotypes from synaptic dysfunction to complex social behaviors, a synthesis previously unattainable due to fragmented individual studies.

Exploration of these phenotypes extends to preliminary pharmacological interventions tested in the canine Shank3 model. Though still nascent and with limited sample sizes, there are intriguing indications that certain compounds may partially ameliorate ASD-like symptoms in these animals. Administration of intranasal oxytocin, a neuropeptide intricately involved in social bonding, was linked to increased maternal behaviors and enhanced attention to human eyes. Additionally, a precisely controlled low-dose psychedelic facilitated a reinstatement of synchronized neural activity—so-called brain-to-brain synchrony—between dogs and their handlers, disrupted by the Shank3 mutation. Furthermore, a pharmacological agent aimed at normalizing aberrant neural excitability was found to rescue deficits in tactile sensitivity and social engagement. While these findings are far from conclusive, they energize a research trajectory focused on translational therapeutics with greater fidelity than previous models.

The choice to utilize dogs in genetic and behavioral neuroscience research is ethically complex, resonating deeply with public sentiment due to dogs’ unique status as companion animals. Acknowledging this, the authors engage earnestly with the bioethical discourse, framing their work within the well-established three Rs of animal research ethics: replacement, reduction, and refinement. They emphasize rigorous ethical oversight in experimental design to minimize animal use without compromising scientific validity. This ethical tension between scientific imperatives and moral responsibilities stands at the heart of the discussion, compelling the field to balance the undeniable potential scientific gains against the profound obligations owed to animal welfare.

Technical challenges present formidable barriers to the widespread adoption of gene-edited canine models. Gene editing efficacy currently hovers around a modest 25%, entailing substantial experimental attrition. Certain mutations exert lethality, further constraining viable subject pools. The logistics of behavioral phenotyping and neuroimaging are complicated by the necessity of prolonged training protocols, sometimes requiring up to two years for animals to habituate to procedures like functional brain imaging. Moreover, the suite of neuroscientific tools and resources optimized for rodent research remains comparatively undeveloped for dogs. Addressing these technical constraints will require collaborative efforts spanning molecular genetics, veterinary science, neuroethology, and ethology.

Looking toward the future, the authors advocate for intensified interdisciplinary collaborations that integrate molecular biology, clinical psychiatry, animal behavior, and neuroscience to refine the canine model further. Improvements in gene-editing precision, development of minimally invasive behavioral and imaging paradigms, and enhanced humane training methodologies are critical milestones. These advances promise not only to deepen understanding of autism’s biological substrates but also to expedite the translation of novel therapeutics from bench to bedside by leveraging the dog’s unique sociobiological platform.

Ultimately, the dog embodies more than a mere experimental subject; it serves as a biological translator that encapsulates a profound evolutionary dialogue between species. This animal, shaped by tens of thousands of years of companionship and mutual adaptation, offers a mirror through which humanity may better decode the neural and behavioral intricacies of its own social fabric. The Perspective concludes with a sober yet hopeful vision: that by inviting this ancient companion into the fold of cutting-edge neuroscience, we unlock a transformative lens into the biology of connection, one that may finally surmount the longstanding impasse in autism therapy development.

The article titled “Emerging gene-edited dog models for autism spectrum disorder” embraces an Open Access model and can be accessed in Genomic Psychiatry as of 24 June 2026. It presents a meticulously reviewed synthesis that not only challenges prevailing paradigms but also opens promising avenues for future research in autism biology and treatment. Such innovative approaches underscore the shifting landscape of psychiatric genetics, calling for models that are both scientifically robust and ethically conscientious.

Subject of Research: Animals
Article Title: Emerging gene-edited dog models for autism spectrum disorder
News Publication Date: 24 June 2026
Web References: https://doi.org/10.61373/gp026p.0036
References: Yuan S, Shi Q, Zhao H, Guo K, Jiang Y-H, Zhang YQ. Emerging gene-edited dog models for autism spectrum disorder. Genomic Psychiatry 2026. DOI: https://doi.org/10.61373/gp026p.0036. Epub 2026 Jun 24.
Image Credits: Yong Q. Zhang
Keywords: Autism, Developmental disabilities, Diseases and disorders, Clinical psychiatry, Psychiatry, Psychiatric disorders, Mental health, Clinical psychology, Psychological science, Biological models, Animal models, Dogs

Social functioning has long been recognized as a core facet of autism, yet prior research often paints a fragmented and inconclusive picture due to the diversity of behavioral domains studied and the developmental stages explored. By systematically clustering 22 distinct social components into five overarching domains, this research offers clarity, revealing substantive group differences between autistic and neurotypical individuals. The overall effect size, represented by Hedges’ g of approximately -0.744, highlights a robust disparity in social functioning, affirming the pervasive nature of these challenges in autism.

A particularly salient contribution of this study lies in its temporal mapping of social deficits. The earliest detectable deviations were found in motivation-based processes as early as six months of age. This insight shifts the focus towards infancy, underscoring the need for early detection and intervention strategies. Following this, disparities in motor skills, emotional processing, and inferential abilities emerged sequentially, suggesting a developmental cascade where foundational social mechanisms underpin more complex social cognition.

Intriguingly, the analysis also uncovers age-related divergences in social functioning, with some skills showing improvement over time despite the persistent overarching difference. Such plasticity challenges deterministic views of autism, instead supporting dynamic models where developmental interventions or environmental factors might mitigate certain social deficits.

The study delves deeper by exploring the interrelations across the identified domains, revealing that autistic individuals display stronger interdependencies between social components compared to their neurotypical peers. This stronger cross-domain connectivity suggests a distinctive organizational architecture in the autistic brain’s social functioning, potentially reflecting compensatory mechanisms or unique developmental pathways.

Methodologically, the research acknowledges significant heterogeneity across studies, including differences in sample sizes, cultural contexts, and assessment tools. This variability inevitably tempers the interpretation of findings, emphasizing the necessity for standardized protocols in future research to ensure replicability and generalizability. Moreover, the predominance of Western populations highlights an urgent call to diversify study cohorts, capturing broader cultural and socio-economic factors affecting social development in autism globally.

The authors offer compelling evidence supporting a serial, hierarchical model of social functioning wherein motivational deficits trigger downstream effects on motor, emotional, and inferential domains. This model aligns with neurodevelopmental theories suggesting that early disruptions in social motivation undermine the acquisition of higher-order social skills, culminating in the complex social impairments characteristic of autism.

From a clinical perspective, these findings hold immense promise for refining autism subtyping approaches. Instead of a monolithic diagnosis, recognizing distinct profiles based on domain-specific social functioning trajectories can enable precision-targeted interventions. Timing is also crucial; the early emergence of motivational deficits points to the potential efficacy of interventions administered during infancy or early childhood.

Furthermore, this meta-analysis foregrounds neurodiversity-informed research paradigms and policy initiatives. By highlighting developmental trajectories and interdomain dynamics unique to autism, the work advocates for strengths-based models that balance challenges with recognition of diverse social capabilities and adaptive strategies utilized by autistic individuals.

This comprehensive review also sheds new light on motor behaviors, often marginalized in autism research despite their early onset and fundamental role in social interaction. The prominence of motor deficits alongside social motivation implicates sensorimotor integration as a critical avenue for therapeutic exploration, potentially transforming intervention design.

Emotion processing, another domain examined extensively, exhibited distinctive developmental patterns that may influence social reciprocity and emotional understanding. These insights emphasize the importance of tailoring social-emotional learning programs to address neurodevelopmental stages and domain-specific challenges.

Equally revealing is the heterogeneity in inferential capacities — including theory of mind and perspective-taking skills — which showed later emergence but maintained strong interrelations with other social domains. Understanding these cognitive components’ position in the developmental hierarchy offers new avenues for cognitive training and support measures.

Finally, the research underscores the vital role of culturally sensitive methodologies given the underrepresentation of diverse populations. Social norms, communication styles, and cultural values all shape social functioning expressions; thus, including a wider array of cultural contexts will enrich understanding and ensure globally relevant findings.

Looking ahead, this comprehensive meta-analysis sets a new standard for precision in autism research and calls for integrative, developmentally informed, and culturally attuned approaches. Its findings may revolutionize both foundational science and real-world applications in diagnosis, intervention, and policy-making, ultimately fostering improved social well-being and inclusion for autistic individuals worldwide.

Subject of Research: Social functioning in autism spectrum disorder across development and behavioral domains.

Article Title: Social functioning in autism: a systematic review and meta-analysis.

Article References:
Li, S., Wang, H., Chen, G. et al. Social functioning in autism: a systematic review and meta-analysis. Nat Hum Behav (2026). https://doi.org/10.1038/s41562-026-02457-w

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41562-026-02457-w